Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Graft Versus Host Disease
Related studies linked through entity extraction aliases.
Photopheresis for the Treatment of Acute Graft Versus Host Disease
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil
- Status
- TERMINATED
- Phase
- NA
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)
- Status
- COMPLETED
- Phase
- PHASE3
Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease
- Status
- COMPLETED
- Phase
- PHASE1
Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
High-Dose Cyclophosphamide for Steroid Refractory GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids
- Status
- TERMINATED
- Phase
- NA
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
- Status
- UNKNOWN
- Phase
- NA
Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
- Status
- TERMINATED
- Phase
- PHASE2
Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- N/A
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
- Status
- COMPLETED
- Phase
- PHASE3
Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2